Last Updated 00:00:00
longbridge loading
Company Encyclopedia
name
MEDISAN
002900.SZ
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate mesylate for injection, bismuth potassium citrate granules, pantoprazole sodium for injection, ambroxol hydrochloride and glucose injection, asarone for injection, paracetamol and tramadol hydrochloride tablets, rifamycin sodium for injection, lornoxicam for injection, vecuronium bromide for injection, and vitamin c for injection. It also provides medical devices and cosmetics.
2.788 T
002900.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking198/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-16.31%E
    • Profit Margin-39.08%E
    • Gross Margin40.88%B
  • Growth ScoreE
    • Revenue YoY-25.44%E
    • Net Profit YoY-2978.80%E
    • Total Assets YoY-10.67%E
    • Net Assets YoY-17.24%E
  • Cash ScoreD
    • Cash Flow Margin33.46%D
    • OCF YoY-25.44%E
  • Operating ScoreD
    • Turnover0.23D
  • Debt ScoreC
    • Gearing Ratio46.93%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --